Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib in Patients with Psoriatic Arthritis Biotech Investing
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo plus Yervoy with Two Cycles of Chemotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer Biotech Investing
Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® in Ankylosing Spondylitis Pharmaceutical Investing
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China Medical Device Investing
XTANDI® Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer Pharmaceutical Investing
Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases Medical Device Investing
AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting Biotech Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
